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Abstract
Background: Stigma is a major issue across various society and cultures, and few studies focus on the perception
of stigma by Chinese patients with schizophrenia. In the current cross-sectional study, we sought to assess the
extent of internalized stigma among outpatients with schizophrenia in China and to investigate whether education
level correlated with the experience of stigma.
Methods: Outpatients with schizophrenia were evaluated using the brief psychosis rating scale (BPRS), the positive
and negative syndrome scale (PANSS), the clinical global impression-severity of illness (CGI-SI) scale and the Stigma
Scale for Mental Illness (SSMI 2C). Patients were categorized into the high education and low education group
according to their educational levels.
Results: One hundred thirty-three subjects were included in the study. Their mean course of illness was 4.32 ± 6.14 years
(range, 1 month to 15 years). Their mean BPRS score was 19.87 ± 5.46, their mean PANSS score was 44.11 ± 13.1, and
their mean CGI-SI score was 2.22 ± 0.81. In addition, the mean SSMI 2C score of the high education group (7.15 ± 0.98)
was markedly higher than that of the low education group (5.75 ± 0.79, P < 0.05). The mean domain I score of the high
education group (2.30 ± 0.76) was comparable to that of the low education group (2.07 ± 0.78, P > 0.05). The mean
domain II score of the high education group (2.42 ± 0.96) was markedly higher than that of the low education group
(2.01 ± 0.79, P < 0.05). Moreover, the mean domain III score of the high education group (2.43 ± 0.79) was significantly
higher than that of the low education group (1.67 ± 0.77, P < 0.05).
Conclusions: Education level impacts on the perception of stigma by patients with schizophrenia and more
psycho-education should be done to improve patients’ knowledge about schizophrenia.
Keywords: Schizophrenia, Stigma, Brief psychosis rating scale (BPRS), The positive and negative syndrome scale
(PANSS), The clinical global impression-severity of illness (CGI-SI) scale
Background
Schizophrenia is a chronic illness that carries a heavy
burden for the society and the family and individual
patients. Stigma is well established as added burden for
people with schizophrenia [1]. Stigma is a major prob-
lem across different societies, but the particular manifes-
tations of stigma may vary due to apparent or subtle
differences in socially or culturally accepted norms of
behavior imposed on individual patients. Currently, two
major types of stigma are recognized: public or social
and personal stigma. Personal stigma can be 1) perceived
stigma, which is what an individual patient thinks
society’s beliefs are about the stigmatized patient, 2)
experienced stigma, which is actual discrimination an in-
dividual patient has experienced, and 3) self-stigma: a
product of the internalization of public stigma. In inter-
nalized or self-stigma, an individual patient gradually
assimilates public stereotypes of mental illness to such a
degree that the patient progressively loses his or her
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perception of himself or herself, which ultimately leads
to changes in his or her behavior in a way that are con-
sistent with the internalized perceptions [2]. Thorough
investigation of the extent and correlates of internalized
stigma is essential to planning for recovery programs for
patients with schizophrenia.
Stigma toward patients with schizophrenia in Chinese
societies is pervasive, frequently resulting in internaliza-
tion of these negative conceptions and loss of self-
esteem. Chen et al. [3] interviewed the family members
of 72 patients with severe mental illness using the Family
Stigma Interview (FSI) and found stigma was pervasive
in the family members, especially if their children had
higher levels of education. In 2005, Gao et al. [4] sur-
veyed 225 convalescent patients with schizophrenia and
their family members at 3 specialty hospitals in Beijing.
They found that 42 % of the patients experienced unfair
treatment at jobs and 56 % of their family members hid
the illness from others to avoid discrimination. Huang et
al. at Shanghai Changning District Mental Hospital [5]
studied 209 patients with mental illness who were hospi-
talized for >12 months and found that stigma was
pervasive. Phillips et al. [6] interviewed 1491 patients
with schizophrenia in 5 mental illness institutions be-
tween 1990 and 2000 using the Camberwell Family
Interview (CFI), 60 % of the patients and their family
members felt moderate impact on their life because
of stigma.
There has been growing interest in stigma in patients
with schizophrenia including the etiology of stigma, the
self-perception of patients with schizophrenia and im-
pact of stigma on patients with schizophrenia and their
family. The studies on outpatients with schizophrenia by
Ritshera [7] and Sartorius [8] found that stigma was
present in these patients during convalescence. Prince
[9] also found that a majority (73.2 %) of patients mental
illness had self-derogation and felt being discriminated
against. Ritshera [7] followed up 82 outpatients with
mental illnesses for 4 months and found one third of the
patients had high levels of self-stigma, which may meet
the criteria for depression and 2/5 of the patients
reported social regression while only one fourth of the
patients exhibited high level stigma resistance. Schulze
et al. [10] interviewed 25 German patients with schizo-
phrenia and found that almost half of them (49 %) expe-
rienced discrimination during social activities and
exhibited perception of stigma. Chee et al. [11] studied
600 patients with mental illness at specialty and compre-
hensive hospitals in Singapore, almost half (48.6 %) of
them felt that others looked down upon them, and
slightly more than one third (37.1 %) of them felt being
discriminated against in looking for jobs, and more than
half (59.2 %) of the patients and 38.8 % believed that
others would avoid him or her upon learning his or her
condition. However, most of our understanding about
internalized stigma in patients with schizophrenia comes
from studies in Western countries.
Little evidence is available from China on internalized
stigma and its risk factors. A recent hospital-based study
of 441 patients with mental illness in China showed that
stigma or lack of knowledge may hamper treatment for
mental illness [12] In China, outpatients with schizo-
phrenia account for more than 90 % of the total popula-
tion with schizophrenia in China and constitute a
particularly important group for study [13]. Patients with
higher levels of education may have better understan-
ding of their own illness by participating online support
forums, reading articles about the traits of their illness
such as easy recurrence, and the need for long term
medication and prognosis, which may add on to the per-
ception of stigma. On the other hand, patients with
lower levels of education may lack such knowledge.. In
the current exploratory cross-sectional study, we sought
to assess the extent of internalized stigma among outpa-
tients with schizophrenia and to investigate whether
education level correlated with experience of stigma.
Methods
Patients
We carried out an exploratory cross-sectional-study of
outpatients with schizophrenia who sought medical
treatment at our hospital between January 2010 and
January 2013. Subjects were screened for eligibility by
reviewing the medical records of patients attending
regular follow-up appointments. A patient was eligible
for inclusion 1) if he or she was aged between 20 and
70 years of age; 2) if he or she met the diagnostic criteria
for schizophrenia according to the International Classifi-
cation of Diseases (ICD-10) [14]; 3) if he or she achieved
remission after therapy with antipsychotic agents as de-
fined by disappearance of mental symptoms, recover of
insight, better social functioning and a brief psychosis
rating scale (BPRS) score <30 [15]; 4) if he or she had no
concurrent severe systemic diseases; 5) if there was no
apparent abnormality in routine blood and urine chem-
istries, liver function or electrocardiogram (ECG). Indi-
viduals with clinically established impairment of insight,
significant cognitive impairment or substance abuse in
the previous three months were excluded.
Ethical approval
The study protocol was approved by Tongde Hospital
Ethics Committee and all study participants or their
legal surrogates provided written informed consent.
Patient evaluation
Patients were assessed for eligibility at a screening
visit, with eligible patients returning for a baseline
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assessment in approximately one week, and then evalu-
ated at subsequent follow-up visits. Patients were evalu-
ated using the BPRS, the positive and negative syndrome
scale (PANSS), the clinical global impression-severity of
illness (CGI-SI) scale (1 point: very much improved; 7
points: very much worse) and the Stigma Scale for Men-
tal Illness (SSMI 2C). The 27-item SSMI 2C is reported
to have excellent internal consistency with an alpha of
0.91 and a test–retest correlation of 0.90 [16]. All three
clinicians evaluating the patients were trained in using
the SSMI 2C scale for this study with a kappa value of
0.91. It has 3 domains: domain I is the discrimination
domain containing 12 items, which evaluates the degree
of discrimination against the subjects due to the illness;
domain II is the disclosure domain containing 9 items,
which evaluates the degree of disclosure by the subjects;
domain III is the positive aspects domain containing 6
items, which evaluates the intensity of perception of the
disease by patients. The subscores from the three do-
mains of SSMI 2C were added and higher scores indi-
cate greater degree of stigma. The term “mental illness”
was used throughout the questionnaire, but in the
questionnaire respondents were encouraged to “think
of it as whatever you feel is the best term for it.” Each
item was rated on a 4-point Likert scale ranging from
1 = strongly disagree to 4 = strongly agree, with higher
scores indicating higher internalized stigma. Evaluation
was carried out by two senior psychiatrists and mean
scores were reported.
All patients were evaluated by mental illness specialists
who had been specifically trained in ICD-10 for this
study with a kappa value of 0.85.
Safety
In addition, vital signs and adverse events were moni-
tored at baseline and post drug therapy using the
treatment-emergent symptom scale (TESS) (NIMH,
1973). Safety assessments were based mainly on the
occurrence, frequency, and severity of adverse events
and were also based on comprehensive indexes, in-
cluding physical examination, electrocardiography,
and routine laboratory investigations. For all adverse
events, where necessary, patients were withdrawn
from the study.
Statistical analysis
All results were expressed as mean ± SD and analyzed
using the SPSS software version 15.0 (SPSS Inc.,
Chicago, IL). Student’s t test was used to compare
BPRS, PANSS, TESS and CGI scores between two
groups. Chi square test was used to compare diffe-
rences in SSMI 2C scores and demographics. P < 0.05
was considered statistically significant.
Results
Demographic and disease characteristics of the study
subjects
Two hundred thirty seven subjects were screened and
133 subjects were eligible for the study. Demographic
and baseline characteristics of the study participants
are shown in Table 1. The mean age of the study
subjects was 32.05 ± 8.95 (range, 20 to 57) years and
there were slightly fewer female patients (43.9 %) than
male patients (54.1 %). Their mean course of illness
was 4.32 ± 6.14 years (range, 1 months to 15 years).
Their mean BPRS score was 19.87 ± 5.46, their mean
PANSS score was 44.11 ± 13.1, and their mean CGI-SI
score was 2.22 ± 0.81. In addition, their mean SSMI
2C score was 6.49 ± 0.9.
We further analyzed the clinical records of patients
according to levels of education. Patients who had
received high school education or above and those
who had received lower levels of education were
comparable in demographic characteristics. They also
had comparable BPRS score [high school or above,
19.34 ± 5.32 vs. middle school or below, 20.45 ± 5.61;
P > 0.05], PANSS scale scores [high school or above,
44.06 ± 12.85 vs. middle school or below, 44.17 ±
13.38; P > 0.05], and CGI scores [high school or
above, 2.13 ± 0.84 vs. middle school or below, 2.32 ±
0.78; P > 0.05] (Table 1).
Most patients (92.5 %, 123/133) took atypical drugs.
The mean baseline TESS score was not statistically dif-
ferent compared to the mean post-therapy TESS score
(P > 0.05). Common side effects are listed in Table 2.
There was no statistical difference in the frequency of
side effects between patients receiving high school edu-
cation or above and those receiving middle school or
below (P > 0.05).
Education and internalized stigma
As shown in Table 3, the mean SSMI 2C score of pa-
tients receiving high school education or above was
7.15 ± 0.98, which was markedly higher than that of
patients receiving middle school education or below
(5.75 ± 0.79) (P < 0.05). The mean domain I score of
patients receiving high school education or above was
2.30 ± 0.76, which was comparable to that of patients
receiving middle school education or below (2.07 ±
0.78, P > 0.05). The mean domain II score of patients
receiving high school education or above was 2.42 ±
0.96, which was markedly higher than that of patients
receiving middle school education or below (2.01 ±
0.79, P < 0.05). Moreover, the mean domain III score
of patients receiving high school education or above
was 2.43 ± 0.79, which was significantly higher than
that of patients receiving middle school education or
below (1.67 ± 0.77, P < 0.05).
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Discussion
Our study revealed no marked difference in demograph-
ics, BPRS scores, PANSS scale scores and CGI scale
scores and TESS scores among patients with different
education backgrounds during convalescence. The side
effects were mild and less frequent in our patients,
which may be related to our use of atypical anti-
psychotic drugs with benign safety profile, thus avoiding
aggravation of internalized stigma of patients with
schizophrenia due to side effects of anti-psychotic drugs
[17]. We used SSMI 2C to determine internalized stigma
of patients with schizophrenia with different educational
backgrounds. We found no significant difference in dis-
crimination domain scores among patients with different
education backgrounds, suggesting that, regardless of
educational background, patients with schizophrenia are
reluctant to reveal their mental illness to others.
Internalized stigma leads to self-devaluation, shame
and social withdrawal, rendering it difficult to over-
come barriers to establish relationships and seek em-
ployment, seriously hindering the recovery process. It
is important to help patients to cope with internalized
stigma and to build up individual resistance in order
to improve their well-being. The first step towards
this goal is an understanding of internalized stigma in
patients with schizophrenia. However, there is scant
data on the presence of stigma in Chinese patients
with schizophrenia. In the current study, we surveyed
the presence of stigma in Chinese outpatients with
schizophrenia and found that internalized stigma was
pervasive in our study subjects. We further found that
educational level was an important factor on percep-
tion of stigma by patients with schizophrenia: those
who had high school education or above exhibited
markedly higher SSMI 2C scores than those with mid-
dle school education or below.
Table 2 Side effects in the study participants
Variables High school
or above,
n = 68 (n, %)
Middle school
or below,
n = 65 (n, %)
P
Extrapyrimidal side effects
Muscle stiffness 3, 4.4 3, 4.6 >0.05
Tremor 1, 1.5 2, 3 >0.05
Twisting movement 1, 1.5 0, 0 >0.05
Immobility 2, 2.9 2, 3 >0.05
Cholinergic side effects
Dry mouth 3, 4.4 5, 7.7 >0.05
Blurred vision 5, 7.4 6, 9.2 >0.05
Stuffy nose 4, 5.9 5, 7.7 >0.05
Salivation 3, 4.4 2, 3 >0.05
Constipation 4, 5.9 6, 9.2 >0.05
Table 1 Demographic and baseline characteristics of the study subjects (±S)
All patients High school or above Middle school or less t’ P
No. of patients 133 70 63
Age, years
Mean (SD) 32.05 ± 8.95 32.30 ± 8.67 31.78 ± 9.26 0.448 (υ = 129) >0.05
Range 20–57 20–56 22–57
Gender, n (%)
Male 72 (54.1) 39 (55.7) 33 (52.4) 0.046 (χ2) >0.05
Drugs >0.05
Atypical 123 64 59
Typical 10 6 4
Course of illness, years
Mean (SD) 4.32 ± 6.14 4.07 ± 6.37 4.6 ± 5.87 0.298 >0.05
Range 0.08–15 0.17–13 0.08–15
BPRS scores
Mean (SD) 19.87 ± 5.46 19.34 ± 5.32 20.45 ± 5.61 1.17 >0.05
PANSS scores
Mean (SD) 44.11 ± 13.1 44.06 ± 12.85 44.17 ± 13.38 0.071 >0.05
CGI-SI
Mean (SD) 2.22 ± 0.81 2.13 ± 0.84 2.32 ± 0.78 0.73 >0.05
SSMI 2C
Mean (SD) 6.49 ± 0.9 7.15 ± 0.98 5.75 ± 0.79 12.866 <0.05
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With advances in the treatment of schizophrenia,
psychiatrists increasingly pay attention to the manage-
ment of mental health of psychiatric patients. It is well
established that discrimination and stigma pose great
barrier to the recovery of patients with schizophrenia
[18], and stigma of patients with schizophrenia im-
pacts on patient behavior in seeking medical therapy
and also their adherence to therapy [7]. We have pre-
viously shown that stigma is pervasive in patients with
schizophrenia during convalescence [19], and there is
difference in internalized stigma among urban and
rural patients with schizophrenia. Here, we further
showed that education level also contributes to differ-
ences in internalized stigma in patients with schizo-
phrenia, suggesting that proper interventions should
be undertaken to tackle internalized stigma of patients
with schizophrenia, which will help planning for re-
covery programs for and improvement of patients with
schizophrenia.
Our study demonstrated that these patients, despite
their different educational backgrounds, all experienced
discrimination or humiliation in life and felt that life
was not fair, indicating development of intense stigma
resistance in these patients. Furthermore, patients with
schizophrenia of different educational backgrounds ex-
hibited marked difference in concealment domain
scores. Those who had received high school education
or above were more likely to conceal their illness from
others than those who had received lower levels of edu-
cation. They were more likely to receive psychotherapy,
Table 3 The Stigma Scale for Mental Illness (SSMI 2C) score stratified by education
High school or above
(n = 70)
Middle school or below
(n = 63)
P
Discrimination factor 2.30 ± 0.76 2.07 ± 0.78 >0.05
1. I was discriminated against in education because of my mental illness. 2.11 ± 0.67 2.17 ± 0.58
2. I sometimes felt discriminated against because of my mental illness. 2.25 ± 0.57 2.13 ± 0.69
7 I was discriminated against by my superiors because of my mental illness. 1.84 ± 0.82 1.82 ± 0.75
8. I was discriminated against by police because of my mental illness. 1.57 ± 0.76 1.69 ± 0.68
10. I felt very lonely because of my mental illness. 2.28 ± 0.68 1.78 ± 0.79
12. I would have had more opportunities if I had no mental illness. 2.87 ± 0.95 1.90 ± 0.82
17. I felt angry at the attitude of others toward my mental illness. 2.64 ± 0.77 2.06 ± 0.74
18. I encounter no trouble due to my mental illness. 2.27 ± 0.87 1.82 ± 0.78
19 I felt discriminated against by medical staff due to my mental illness. 2.36 ± 0.82 2.86 ± 0.98
20. People avoided me due to my mental illness. 2.74 ± 0.86 1.96 ± 0.79
21. I was humiliated by others due to my mental illness. 2.30 ± 0.76 2.85 ± 0.93
25. I feel life is unfair because of my mental illness. 2.58 ± 0.94 1.86 ± 0.79
Concealment factor 2.42 ± 0.96 2.01 ± 0.79 <0.05
5. I am worried about telling others that I am on psychotherapy. 2.84 ± 0.87 1.88 ± 1.09
11. I fear reaction by others if they find out I have mental illness. 2.43 ± 0.96 1.93 ± 0.78
13. I do not care if my neighbors know about my mental illness. 1.33 ± 0.74 1.29 ± 0.67
14. I will admit having mental illness if I am interviewed for a job. 0.71 ± 0.38 0.88 ± 0.49
15. I fear telling others that I am on therapy for mental illness. 3.02 ± 0.69 2.67 ± 0.93
16. I had to keep my mental illness secrete due to attitude of others. 2.73 ± 0.95 1.89 ± 0.72
24. I do not like to tell others that I am having mental illness. 2.98 ± 1.87 2.53 ± 0.82
26. I felt it was necessary to conceal my mental illness from my friends. 2.76 ± 0.77 2.89 ± 0.79
27. I found it hard to tell others about my mental illness 3.04 ± 0.87 2.11 ± 0.84
Positive effect factors 2.43 ± 0.79 1.67 ± 0.77 <0.05
3. I have become more considerate because of my mental illness. 2.52 ± 0.70 1.52 ± 0.73
4 I do not feel terrible because of my mental illness. 2.22 ± 0.94 1.86 ± 0.89
6. People understand my mental illness. 2.01 ± 0.84 1.77 ± 0.79
9. I have become more tolerant of others because of my illness. 2.63 ± 0.76 1.22 ± 0.64
22. I have become a stronger person because of my illness. 2.93 ± 0.76 2.06 ± 0.72
23. I do not feel ashamed of my mental illness 2.31 ± 0.73 1.57 ± 0.83
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but were also less likely to disclose to others that
they were on psychotherapy or anti-psychotherapeutic
drugs. In addition, they were more sensitive to atti-
tudes by others. On the other hand, patients who had
received high school education or above were more
likely to receive psychological counseling than anti-
psychotherapeutic drugs and were more tolerant of
others. Patients who had received middle school or
below were more likely to focus on somatic illness
rather than mental issues, indicating it is important
to educate these patients about mental health. Fur-
thermore, patients who received high school educa-
tion or above had markedly higher scores in positive
affect domain scores than those who received lower
levels of education. They were more receptive to
others and did not feel terrible and more independent
compared to patients who received middle school
education or below.
Because of the pervasive nature of stigma in patients
with schizophrenia [19], apart from active drug therapy
for preventing stigma, psychological education and
aggressive psychological intervention are important for
eliminating or alleviating stigma of patients with schizo-
phrenia [20, 21]. As patients with different education
backgrounds differ in stigma traits, psychological inter-
vention should be individualized. Our findings suggest
that patients who had received high school education or
above should be assisted in their early return to the soci-
ety and assumption of their work and family role.
Patients who had received middle school education or
less should be helped with restoration of self-confidence
and provided with mental health education.
We did not address the issue of insight and stigma in
the exploratory study. The relation between insight and
education and stigma remains subtle and yet important,
and insight in schizophrenia requires specific evaluation
such as with the Birchwood’s Psychosis Insight Scale
(BPIS). We will consider addressing the issue of insight
and education and their relation with stigma in future
studies by using scales such as the BPIS. The current
study is also limited by its cross-sectional nature and the
size of the study cohort. In addition, this is a single cen-
ter experience with most patients coming from within
the same province. Furthermore, the findings from the
current study need to be confirmed by prospective mul-
ticenter study involving a larger patient population with
longer follow up period.
Conclusion
Our exploratory cross-sectional-study of outpatients with
schizophrenia demonstrates that education level impacts
on the perception of stigma by patients with schizophrenia
and more psycho-education should be done to improve
patients’ knowledge about schizophrenia.
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